132 related articles for article (PubMed ID: 100615)
1. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
Gavrell GJ; Lewis RW; Meehan WL; Leblanc GA
J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615
[TBL] [Abstract][Full Text] [Related]
2. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
Mukamel E; Zitron S; Nissenkorn I; Servadio C
Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
[TBL] [Abstract][Full Text] [Related]
4. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
Wang SH
Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
[TBL] [Abstract][Full Text] [Related]
5. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin].
Kumamoto Y; Tsukamoto T; Tamiya T; Takatsuka K; Furuya S; Yokoyama E; Honma A; Aoyama T; Tanda H; Kato S
Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659
[TBL] [Abstract][Full Text] [Related]
6. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
[TBL] [Abstract][Full Text] [Related]
7. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
Toulouse J; Bouffier B; Etievent JP; Bittard M
J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
[TBL] [Abstract][Full Text] [Related]
8. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
Durán R; Reina GR; Hontoria JM; Merino C; Olivier C; Carballido J
Actas Urol Esp; 1989; 13(1):19-23. PubMed ID: 2496583
[TBL] [Abstract][Full Text] [Related]
9. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
Zhang SX; Deng XZ; Tang XD
Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
[No Abstract] [Full Text] [Related]
10. A comparison of treatment methods for the prophylaxis of recurrent superficial bladder tumors.
Rodrigues Netto Júnior N; Lemos GC
J Urol; 1983 Jan; 129(1):33-4. PubMed ID: 6402610
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
Nocks BN; Nieh PT; Prout GR
J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
[TBL] [Abstract][Full Text] [Related]
12. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
Wescott JW
J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
[No Abstract] [Full Text] [Related]
13. The effect of intravesical thio-tepa on normal and tumor urothelium.
Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
[TBL] [Abstract][Full Text] [Related]
14. Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa.
Prout GR; Koontz WW; Coombs LJ; Hawkins IR; Friedell GH
J Urol; 1983 Oct; 130(4):677-80. PubMed ID: 6411939
[TBL] [Abstract][Full Text] [Related]
15. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma.
Brosman SA
J Urol; 1982 Jul; 128(1):27-30. PubMed ID: 6809960
[TBL] [Abstract][Full Text] [Related]
16. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
Kierfeld G; Mellin P
Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
[No Abstract] [Full Text] [Related]
17. Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.
Csellár M; Csontai A
Int Urol Nephrol; 1979; 11(1):39-44. PubMed ID: 112079
[TBL] [Abstract][Full Text] [Related]
18. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
[TBL] [Abstract][Full Text] [Related]
19. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
[TBL] [Abstract][Full Text] [Related]
20. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
Horn Y; Eidelman A; Walach N; Yuval E; Markowitz A
J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
